Description
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Purity | ≥95% |
|---|---|
| Formula | C51H85N13O21 |
| Formula Wt. | 1216.32 |
| Synonym | IL-6R |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Bosze S, Hudecz F, Igaz P, et al. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells. Biol Chem. 2003 Mar;384(3):409-21. PMID: 12715892.
Progesterone derivative; Cyp17A1 inhibitor.
Inhibitor of FAK and ALK.
NSAID; COX-2 inhibitor.
Mouse selective STING agonist.
pan-RAF inhibitor
Thymidylate synthase inhibitor, potential SHMT,...
Bisphosphonate; squalene synthase inhibitor.
Imidazothiazole; alkaline phosphatase inhibitor...
PDE5 inhibitor.
Caspase 3 substrate.
VEGFR, PDGFR, c-Kit inhibitor.
Tankyrase inhibitor.
Protease inhibitor.
mTORC1 inhibitor.
Thiazide-like diuretic; Kv7.1 and minK K+ chann...
Nitrosourea, DNA cross-linker.
H+/K+ ATPase and ROCK-2 inhibitor.
NK1 antagonist.
β-lactam; penicillin binding protein inhibitor...
Mineralocorticoid antagonist.